UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Bionano Genomics
BNGO
$13.3M
| $498K | ﹤0.01% |
568
| – | – |
|
2127
Xperi
XPER
$348M
| $497K | ﹤0.01% |
+57,775
| New | +$661K |
|
|
PYCR
2128
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $497K | ﹤0.01% |
20,297
+223
| +1% | +$6.17K |
|
2129
PAR Technology
PAR
$735M
| $496K | ﹤0.01% |
19,021
+421
| +2% | +$10.8K |
|
|
CUTR
2130
DELISTED
Cutera, Inc.
CUTR
| $495K | ﹤0.01% |
11,200
+1,851
| +20% | +$84.4K |
|
2131
Joby Aviation
JOBY
$8.55B
| $489K | ﹤0.01% |
+146,100
| New | +$592K |
|
|
PLL
2132
DELISTED
Piedmont Lithium
PLL
| $487K | ﹤0.01% |
11,071
+1,490
| +16% | +$82.6K |
|
|
BRSP
2133
BrightSpire Capital
BRSP
$648M
| $485K | ﹤0.01% |
77,897
+20,777
| +36% | +$144K |
|
|
TPIC
2134
DELISTED
TPI Composites
TPIC
| $485K | ﹤0.01% |
47,792
| – | – |
|
|
AAN
2135
DELISTED
The Aaron's Company Inc
AAN
| $484K | ﹤0.01% |
40,516
+871
| +2% | +$9.33K |
|
2136
Artivion
AORT
$1.32B
| $480K | ﹤0.01% |
39,619
| – | – |
|
2137
OneSpan
OSPN
$618M
| $479K | ﹤0.01% |
42,794
| – | – |
|
2138
Crinetics Pharmaceuticals
CRNX
$8.92B
| $477K | ﹤0.01% |
26,066
| – | – |
|
2139
Quanterix
QTRX
$190M
| $474K | ﹤0.01% |
34,190
| – | – |
|
2140
CEVA Inc
CEVA
$1.08B
| $473K | ﹤0.01% |
18,490
| – | – |
|
2141
DXP Enterprises
DXPE
$2.98B
| $473K | ﹤0.01% |
17,160
+8,260
| +93% | +$220K |
|
2142
Universal Corp
UVV
$1.27B
| $472K | ﹤0.01% |
8,930
| – | – |
|
2143
MarineMax
HZO
$788M
| $471K | ﹤0.01% |
15,101
-13,299
| -47% | -$418K |
|
2144
Sportsman's Warehouse
SPWH
$46M
| $469K | ﹤0.01% |
49,864
| – | – |
|
2145
Vishay Precision Group
VPG
$914M
| $469K | ﹤0.01% |
+12,134
| New | +$442K |
|
2146
DMC Global
BOOM
$157M
| $468K | ﹤0.01% |
24,098
+11,498
| +91% | +$212K |
|
2147
Insteel Industries
IIIN
$625M
| $464K | ﹤0.01% |
+16,872
| New | +$462K |
|
2148
Montauk Renewables
MNTK
$255M
| $464K | ﹤0.01% |
42,090
+5,323
| +14% | +$71.2K |
|
2149
Seres Therapeutics
MCRB
$48.9M
| $461K | ﹤0.01% |
4,118
| – | – |
|
|
LUCK
2150
Lucky Strike Entertainment
LUCK
$911M
| $461K | ﹤0.01% |
34,216
+1,427
| +4% | +$19.3K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.